Certain subsets of renal neoplasms behave differently, but why?

Editorial

J M Holland. J Urol. 1996 Jul.

. 1996 Jul;156(1):40.

doi: 10.1016/s0022-5347(01)65931-7.

No abstract available

Comment on

Immunochemotherapy for metastatic renal cell carcinoma using a regimen of interleukin-2, interferon-alpha and 5-fluorouracil.
Hofmockel G, Langer W, Theiss M, Gruss A, Frohmüller HG. Hofmockel G, et al. J Urol. 1996 Jul;156(1):18-21. J Urol. 1996. PMID: 8648791 Clinical Trial.
Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1.
Brown JA, Takahashi S, Alcaraz A, Borell TJ, Anderl KL, Qian J, Persons DL, Bostwick DG, Lieber MM, Jenkins RB. Brown JA, et al. J Urol. 1996 Jul;156(1):31-5. J Urol. 1996. PMID: 8648831
Nephron sparing surgery in patients with metastatic renal cell carcinoma.
Krishnamurthi V, Novick AC, Bukowski R. Krishnamurthi V, et al. J Urol. 1996 Jul;156(1):36-9. J Urol. 1996. PMID: 8648832 Clinical Trial.